Pub Date : 2022-12-26DOI: 10.2174/2666082219666221226151805
M. Zinchuk, E. Pashnin, G. Kustov, S. Popova, N. Voinova, A. Gersamia, A. Yakovlev, A. Guekht
To investigate the level of anxiety as well as attitude toward disease and mitigation strategies in people with non-psychotic mental disorders and healthy controls. The new coronavirus disease (COVID-19) pandemic resulted in an unprecedented morbidity and mortality and economic consequences worldwide. Response to pandemic required an urgent and radical change in the medical care delivery with a focus on infectious disease, which is uncommon for most developed countries. Implemented changes led to reduced psychiatric (especially inpatient) care utilization. To investigate the level of anxiety as well as attitude toward disease and mitigation strategies in people with non-psychotic mental disorders and healthy controls. A case-control study (1:4) was conducted during a self-isolation regimen in Moscow. Cases were adult patients with NPMD consequently admitted to the Moscow Research and Clinical Center for Neuropsychiatry. Sex and age-matched controls (individuals who have never sought psychiatric help) were selected from a cohort of 7498 Moscow residents who participated in a largecross-sectional survey delivered via social networks and popular Russian web platforms. The level of the trait but not state anxiety was higher in people with NPMD. People with mental disorders were significantly more often concerned about the negative impact of the COVID-19 pandemic on their lives, were more likely to be confident that they would contract the coronavirus and their disease would be severe, showed suboptimal adherence to mitigation strategies, were dissatisfied with the amount of information they received about the COVID-19 and were more concerned about becoming a victim of domestic violence. People with NPMD have higher level of trait anxiety and are prompted to develop the constellation of maladaptive beliefs toward a pandemic. These beliefs along with the lack of reliable information on coronavirus infection can lead to misunderstanding and disregard of sanitary and self-isolation recommendations. Educational programs and vaccination campaigns should be sensitive to these features of people with NPMD. No
{"title":"Worriers of the pandemic: How people with mental disorders cope with COVID-19 restrictions","authors":"M. Zinchuk, E. Pashnin, G. Kustov, S. Popova, N. Voinova, A. Gersamia, A. Yakovlev, A. Guekht","doi":"10.2174/2666082219666221226151805","DOIUrl":"https://doi.org/10.2174/2666082219666221226151805","url":null,"abstract":"\u0000\u0000To investigate the level of anxiety as well as attitude toward disease and mitigation strategies in people with non-psychotic mental disorders and healthy controls.\u0000\u0000\u0000\u0000The new coronavirus disease (COVID-19) pandemic resulted in an unprecedented morbidity and mortality and economic consequences worldwide. Response to pandemic required an urgent and radical change in the medical care delivery with a focus on infectious disease, which is uncommon for most developed countries. Implemented changes led to reduced psychiatric (especially inpatient) care utilization.\u0000\u0000\u0000\u0000To investigate the level of anxiety as well as attitude toward disease and mitigation strategies in people with non-psychotic mental disorders and healthy controls.\u0000\u0000\u0000\u0000A case-control study (1:4) was conducted during a self-isolation regimen in Moscow. Cases were adult patients with NPMD consequently admitted to the Moscow Research and Clinical Center for Neuropsychiatry. Sex and age-matched controls (individuals who have never sought psychiatric help) were selected from a cohort of 7498 Moscow residents who participated in a largecross-sectional survey delivered via social networks and popular Russian web platforms.\u0000\u0000\u0000\u0000The level of the trait but not state anxiety was higher in people with NPMD. People with mental disorders were significantly more often concerned about the negative impact of the COVID-19 pandemic on their lives, were more likely to be confident that they would contract the coronavirus and their disease would be severe, showed suboptimal adherence to mitigation strategies, were dissatisfied with the amount of information they received about the COVID-19 and were more concerned about becoming a victim of domestic violence.\u0000\u0000\u0000\u0000People with NPMD have higher level of trait anxiety and are prompted to develop the constellation of maladaptive beliefs toward a pandemic. These beliefs along with the lack of reliable information on coronavirus infection can lead to misunderstanding and disregard of sanitary and self-isolation recommendations. Educational programs and vaccination campaigns should be sensitive to these features of people with NPMD.\u0000\u0000\u0000\u0000No\u0000","PeriodicalId":36711,"journal":{"name":"Current Psychiatry Research and Reviews","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2022-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45015284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-12-06DOI: 10.2174/2666082219666221206112951
E. Darin
Organic disorder remains one of the most pressing issues in practical psychiatry, especially a disorder dominated by persistent or recurrent delusions. The difficulty for practitioners is often due to the older age of patients and the burden of concomitant therapeutic diseases. Modern and potentially promising pharmacological drugs developed in recent years include partial agonists of D2 and D3 receptors. Currently, there are insufficient publications of studies on Cariprazine use in various disorders that are not associated with endogenous pathology. The author presented the results of the patient’s clinical examination with a complex of psychodiagnostic techniques, instrumental research methods, observation data in the department, and an analysis of the patient’s medical history. The paper describes the experience of treating a patient with the latest generation antipsychotic drug Cariprazine. The author presents a case report on Cariprazine therapy in a 71-year-old female patient with a persistent organic delusional disorder with concomitant severe somatic illness. Cariprazine showed good efficacy in this case. Delusional symptoms were significantly reduced, and the author noted a reduction in negative symptoms. Mild side effects of the drug quickly resolved in the course of treatment. The key point is that the description of this case may be relevant to justify the need for further clinical studies on Cariprazine. Further clinical studies of the drug in the treatment of various mental pathologies may be in demand by specialists around the world.
{"title":"Case Report: The Experience Using Cariprazine in Organic Delusional Disorder in an Elderly Patient with Concomitant Somatic Pathology, Brief Report","authors":"E. Darin","doi":"10.2174/2666082219666221206112951","DOIUrl":"https://doi.org/10.2174/2666082219666221206112951","url":null,"abstract":"\u0000\u0000Organic disorder remains one of the most pressing issues in practical psychiatry, especially a disorder dominated by persistent or recurrent delusions. The difficulty for practitioners is often due to the older age of patients and the burden of concomitant therapeutic diseases. Modern and potentially promising pharmacological drugs developed in recent years include partial agonists of D2 and D3 receptors. Currently, there are insufficient publications of studies on Cariprazine use in various disorders that are not associated with endogenous pathology.\u0000\u0000\u0000\u0000The author presented the results of the patient’s clinical examination with a complex of psychodiagnostic techniques, instrumental research methods, observation data in the department, and an analysis of the patient’s medical history. The paper describes the experience of treating a patient with the latest generation antipsychotic drug Cariprazine.\u0000\u0000\u0000\u0000The author presents a case report on Cariprazine therapy in a 71-year-old female patient with a persistent organic delusional disorder with concomitant severe somatic illness.\u0000\u0000\u0000\u0000Cariprazine showed good efficacy in this case. Delusional symptoms were significantly reduced, and the author noted a reduction in negative symptoms. Mild side effects of the drug quickly resolved in the course of treatment. \u0000The key point is that the description of this case may be relevant to justify the need for further clinical studies on Cariprazine. Further clinical studies of the drug in the treatment of various mental pathologies may be in demand by specialists around the world.\u0000","PeriodicalId":36711,"journal":{"name":"Current Psychiatry Research and Reviews","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2022-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48618885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-11-14DOI: 10.2174/2666082219666221114114738
Kedar S Prabhavalkar, Mikhil Santosh Kore
Depression, or major depressive disorder, is a mental illness that significantly affects psychosocial functioning and reduces the quality of one’s life. The annual incidence of depression throughout the globe is around 6%. The disorder should be diagnosed at a particular stage for the treatment to be designed. Biomarkers can help to do so with objective pieces of evidence. Various biomarkers like Imaging biomarkers, Molecular biomarkers, Transcriptomic biomarkers, Genetic biomarkers, Neuroendocrine, and Inflammatory biomarkers can be used to diagnose depression. The use of digital sensors has also been reported recently for the determination of depression. This review summarizes various biomarkers to diagnose depression. Further recent updates and related clinical trials are included.
{"title":"Biomarkers for the diagnosis of depression: Recent updates","authors":"Kedar S Prabhavalkar, Mikhil Santosh Kore","doi":"10.2174/2666082219666221114114738","DOIUrl":"https://doi.org/10.2174/2666082219666221114114738","url":null,"abstract":"\u0000\u0000Depression, or major depressive disorder, is a mental illness that significantly affects psychosocial functioning and reduces the quality of one’s life. The annual incidence of depression throughout the globe is around 6%. The disorder should be diagnosed at a particular stage for the treatment to be designed. Biomarkers can help to do so with objective pieces of evidence. Various biomarkers like Imaging biomarkers, Molecular biomarkers, Transcriptomic biomarkers, Genetic biomarkers, Neuroendocrine, and Inflammatory biomarkers can be used to diagnose depression. The use of digital sensors has also been reported recently for the determination of depression. This review summarizes various biomarkers to diagnose depression. Further recent updates and related clinical trials are included.\u0000","PeriodicalId":36711,"journal":{"name":"Current Psychiatry Research and Reviews","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2022-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47631862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-10-28DOI: 10.2174/2666082219666221028102903
U. Barahmand, Ezra Hermann, Aditi Rai, Amisha Tewari, S. Kopyto, Kayla Castellanos
This study aims to examine mechanisms that may account for the comorbidity between social anxiety and depression. We hypothesized that maladaptive metacognitions and anhedonia would serially mediate the link between social anxiety and depression. We tested this notion by collecting data from 208 international, English speaking participants ranging from the ages of 18 to 65 years old using the Social Interaction Anxiety Scale (SIAS), Self-Assessment Anhedonia Scale (SAAS), Patient’s Health Questionnaire-9 (PHQ-9), and Metacognition Questionnaire (MCQ-30). The results show a significant serial mediation effect from social anxiety via beliefs about uncontrollability and danger and anhedonia to depression, with the pathway from social anxiety via reduced beliefs in cognitive confidence and anhedonia to depression not being significant. Furthermore, a direct path from social anxiety to depression was also significant. Findings provide support for both the tripartite model and the self-regulatory executive function model of anxiety and depression. While the findings imply the contributions of other mediating variables, they also indicate that metacognitive therapy with additional focus on anhedonia could be effective in preventing the development of depression.
{"title":"Linking Social Anxiety and Depression: The Role of Metacognitive Beliefs and Anhedonia","authors":"U. Barahmand, Ezra Hermann, Aditi Rai, Amisha Tewari, S. Kopyto, Kayla Castellanos","doi":"10.2174/2666082219666221028102903","DOIUrl":"https://doi.org/10.2174/2666082219666221028102903","url":null,"abstract":"\u0000\u0000This study aims to examine mechanisms that may account for the comorbidity between social anxiety and depression.\u0000\u0000\u0000\u0000We hypothesized that maladaptive metacognitions and anhedonia would serially mediate the link between social anxiety and depression.\u0000\u0000\u0000\u0000We tested this notion by collecting data from 208 international, English speaking participants ranging from the ages of 18 to 65 years old using the Social Interaction Anxiety Scale (SIAS), Self-Assessment Anhedonia Scale (SAAS), Patient’s Health Questionnaire-9 (PHQ-9), and Metacognition Questionnaire (MCQ-30).\u0000\u0000\u0000\u0000The results show a significant serial mediation effect from social anxiety via beliefs about uncontrollability and danger and anhedonia to depression, with the pathway from social anxiety via reduced beliefs in cognitive confidence and anhedonia to depression not being significant. Furthermore, a direct path from social anxiety to depression was also significant.\u0000\u0000\u0000\u0000Findings provide support for both the tripartite model and the self-regulatory executive function model of anxiety and depression. While the findings imply the contributions of other mediating variables, they also indicate that metacognitive therapy with additional focus on anhedonia could be effective in preventing the development of depression.\u0000","PeriodicalId":36711,"journal":{"name":"Current Psychiatry Research and Reviews","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2022-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41283891","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-09-29DOI: 10.2174/2666082218666220929113437
Afsaneh Aminpour, Shiva Soraya, Hamidreza Ahmad khaniha
Substance use disorders are highly prevalent among psychotic patients and are associated with poorer clinical outcomes. The study aimed to investigate the prevalence of psychotic disorders in substance users and the epidemiological features of this population. In a cross-sectional study, we investigated 455 outpatient and inpatient participants with SUD referred to the Iran psychiatric hospital from April 2020 to March 2021. All participants were substance users, referred to Iran psychiatric center to follow up on their comorbidities and psychiatric disorders. The Structured Clinical Interview for DSM-5 (SCID) was used for psychotic disorders and substance use disorder diagnoses. Finally, gathered data were analyzed by SPSS-25. 455 patients were involved in the study. The mean age was 34.66 years, of which 89.7% were men. The most common main substances include methamphetamine (39.1%) and heroin (27%). The Prevalence of psychotic disorder was 36.7%, and the most common type was substance-induced psychotic disorder (26.4%) and schizophrenia (8.4%). There was a significant association between methamphetamine and opium use and the presence of substance-induced psychotic disorder and schizophrenia, respectively (p˂ 0.001). The most common type of substance use was methamphetamine and the most common type of psychotic disorder was substance-induced psychotic disorder. There was a significant association between methamphetamine and opium use and the presence of substance-induced psychotic disorder and schizophrenia, respectively. It should be noted that this was a sample of individuals hospitalized for substance abuse. It was not a general population sample and is very biased toward substance use.
{"title":"Prevalence of comorbidities of psychotic disorders in patients with substance use disorders in Iran Psychiatric Hospital in Tehran, Iran","authors":"Afsaneh Aminpour, Shiva Soraya, Hamidreza Ahmad khaniha","doi":"10.2174/2666082218666220929113437","DOIUrl":"https://doi.org/10.2174/2666082218666220929113437","url":null,"abstract":"\u0000\u0000Substance use disorders are highly prevalent among psychotic patients and are associated with poorer clinical outcomes.\u0000\u0000\u0000\u0000The study aimed to investigate the prevalence of psychotic disorders in substance users and the epidemiological features of this population.\u0000\u0000\u0000\u0000In a cross-sectional study, we investigated 455 outpatient and inpatient participants with SUD referred to the Iran psychiatric hospital from April 2020 to March 2021. All participants were substance users, referred to Iran psychiatric center to follow up on their comorbidities and psychiatric disorders. The Structured Clinical Interview for DSM-5 (SCID) was used for psychotic disorders and substance use disorder diagnoses. Finally, gathered data were analyzed by SPSS-25.\u0000\u0000\u0000\u0000455 patients were involved in the study. The mean age was 34.66 years, of which 89.7% were men. The most common main substances include methamphetamine (39.1%) and heroin (27%). The Prevalence of psychotic disorder was 36.7%, and the most common type was substance-induced psychotic disorder (26.4%) and schizophrenia (8.4%). There was a significant association between methamphetamine and opium use and the presence of substance-induced psychotic disorder and schizophrenia, respectively (p˂ 0.001).\u0000\u0000\u0000\u0000The most common type of substance use was methamphetamine and the most common type of psychotic disorder was substance-induced psychotic disorder. There was a significant association between methamphetamine and opium use and the presence of substance-induced psychotic disorder and schizophrenia, respectively. It should be noted that this was a sample of individuals hospitalized for substance abuse. It was not a general population sample and is very biased toward substance use.\u0000","PeriodicalId":36711,"journal":{"name":"Current Psychiatry Research and Reviews","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2022-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46731145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-09-22DOI: 10.2174/2666082218666220922101408
U. Bhaumik
The coronavirus pandemic of 2019 has resulted in extensive social regulations and affected many aspects of life. It has led to significant stress and adversely impacted the mental health across the globe. The virus has been found to directly increase neuropsychiatric sequelae in those affected. Various other psychosocial factors have also increased the incidence and prevalence of mental health problems worldwide. There was a need for a ramp-up of psychiatric services to support individuals in such a situation. Even after the pandemic, there is a need for improving access to mental health services for the mentally ill as well as those affected by the regulations brought about to tackle the pandemic. Tele psychiatric services are in place throughout the world in different forms and they are the answer to bridging the mental health gap during and in the aftermath of the pandemic. Hence, it is important to continue developing and enhance tele psychiatric services in different countries for supporting and treating individuals affected by the pandemic.
{"title":"Mental health needs in COVID and post-COVID era-how far can Telepsychiatry address the challenges?","authors":"U. Bhaumik","doi":"10.2174/2666082218666220922101408","DOIUrl":"https://doi.org/10.2174/2666082218666220922101408","url":null,"abstract":"\u0000\u0000The coronavirus pandemic of 2019 has resulted in extensive social regulations and affected many aspects of life. It has led to significant stress and adversely impacted the mental health across the globe. The virus has been found to directly increase neuropsychiatric sequelae in those affected. Various other psychosocial factors have also increased the incidence and prevalence of mental health problems worldwide. There was a need for a ramp-up of psychiatric services to support individuals in such a situation. Even after the pandemic, there is a need for improving access to mental health services for the mentally ill as well as those affected by the regulations brought about to tackle the pandemic. Tele psychiatric services are in place throughout the world in different forms and they are the answer to bridging the mental health gap during and in the aftermath of the pandemic. Hence, it is important to continue developing and enhance tele psychiatric services in different countries for supporting and treating individuals affected by the pandemic.\u0000","PeriodicalId":36711,"journal":{"name":"Current Psychiatry Research and Reviews","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2022-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44902672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-08-29DOI: 10.2174/2666082218666220829115417
J. J. Javela, María Antonia Londoño-Cortés, Maria Camila Idárraga-López, L. Cudris-Torres, R. Mercadillo
Understanding how people respond to societal problems requires analyzing the experience and expression of moral emotions (ME). Despite the fact that various research on moral emotions have been conducted in Latin America, this analysis has yet to be completed, despite the fact that it is particularly important due to its link to violence and inequality. The goal of this paper is to evaluate ME research in Latin America and discuss it within the context of a socio-cultural and socio-economic analysis of this region of the world. The PRISMA searching method was applied in Scopus, PubMed, ScienceDirect, Scielo, and Redalyc databases. The findings revealed 58 publications in Latin America that dealt with moral feelings and were consequently studied. Colombia, Mexico, Brazil, and Chile are the countries that have tackled the issue the most. Compassion, devotion, and gratitude were the three most explored MS and associated themes. The impact of moral emotions on persons living in various Latin American environments, as well as their prosocial acts aimed at combating violence and inequality, is revealed.
{"title":"Moral Emotions in the Latin-America: A Socio-cultural and Socio-economic analysis","authors":"J. J. Javela, María Antonia Londoño-Cortés, Maria Camila Idárraga-López, L. Cudris-Torres, R. Mercadillo","doi":"10.2174/2666082218666220829115417","DOIUrl":"https://doi.org/10.2174/2666082218666220829115417","url":null,"abstract":"\u0000\u0000Understanding how people respond to societal problems requires analyzing the experience and expression of moral emotions (ME). Despite the fact that various research on moral emotions have been conducted in Latin America, this analysis has yet to be completed, despite the fact that it is particularly important due to its link to violence and inequality.\u0000\u0000\u0000\u0000The goal of this paper is to evaluate ME research in Latin America and discuss it within the context of a socio-cultural and socio-economic analysis of this region of the world. The PRISMA searching method was applied in Scopus, PubMed, ScienceDirect, Scielo, and Redalyc databases.\u0000\u0000\u0000\u0000The findings revealed 58 publications in Latin America that dealt with moral feelings and were consequently studied. Colombia, Mexico, Brazil, and Chile are the countries that have tackled the issue the most. Compassion, devotion, and gratitude were the three most explored MS and associated themes.\u0000\u0000\u0000\u0000The impact of moral emotions on persons living in various Latin American environments, as well as their prosocial acts aimed at combating violence and inequality, is revealed.\u0000","PeriodicalId":36711,"journal":{"name":"Current Psychiatry Research and Reviews","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2022-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44618869","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-08-23DOI: 10.2174/2666082218666220823153739
S. Kaman, Ankita Sharma, Romi Banerjee
We initiated a systematic review to determine the impact of the SARS-COV-2 virus and its long-term effects - in both symptomatic and asymptomatic cases - on people with or without psychosis. We envisioned that this would give us an insight into effective clinical intervention methods for patients with psychosis during and after the pandemic. The outbreak of the COVID-19 pandemic, the constant transformation of the SARS-COV-2 virus form, exposure to substantial psychosocial stress, environmental change, and isolation have led to the inference that the overall population's mental health could be affected, resulting in an increase in cases of psychosis. We selected fifteen papers that met our inclusion criteria, i.e., those that considered participants with or without psychiatric illness and exposed to SARS-COV-2 infection, for this review and were retrieved via Google, Google Scholar, MEDLINE, PubMed, and PsychINFO Database. There is a dearth of research in understanding how COVID-19 affects people with or without a prior personal history of psychosis. The systematic review summary provides insight into the state of knowledge. Insights from the systematic review have also been reviewed from the salutogenesis model's perspective. There is moderate evidence of new-onset psychosis during the COVID-19 pandemic in which some antipsychotics treated the psychotic symptoms of patients while treating for COVID-19. Suggestions and recommendations are made for preventive and promotive public health strategies. The Salutogenesis model and Positive Psychology Interventions (PPI) provide another preventive and promotive public health management approach.
{"title":"Association between COVID-19 Pandemic and Serious Mental Illness: Systematic Review within Salutogenesis Model for Public Health Management","authors":"S. Kaman, Ankita Sharma, Romi Banerjee","doi":"10.2174/2666082218666220823153739","DOIUrl":"https://doi.org/10.2174/2666082218666220823153739","url":null,"abstract":"\u0000\u0000We initiated a systematic review to determine the impact of the SARS-COV-2 virus and its long-term effects - in both symptomatic and asymptomatic cases - on people with or without psychosis. We envisioned that this would give us an insight into effective clinical intervention methods for patients with psychosis during and after the pandemic.\u0000\u0000\u0000\u0000The outbreak of the COVID-19 pandemic, the constant transformation of the SARS-COV-2 virus form, exposure to substantial psychosocial stress, environmental change, and isolation have led to the inference that the overall population's mental health could be affected, resulting in an increase in cases of psychosis.\u0000\u0000\u0000\u0000We selected fifteen papers that met our inclusion criteria, i.e., those that considered participants with or without psychiatric illness and exposed to SARS-COV-2 infection, for this review and were retrieved via Google, Google Scholar, MEDLINE, PubMed, and PsychINFO Database.\u0000\u0000\u0000\u0000There is a dearth of research in understanding how COVID-19 affects people with or without a prior personal history of psychosis.\u0000\u0000\u0000\u0000The systematic review summary provides insight into the state of knowledge. Insights from the systematic review have also been reviewed from the salutogenesis model's perspective. There is moderate evidence of new-onset psychosis during the COVID-19 pandemic in which some antipsychotics treated the psychotic symptoms of patients while treating for COVID-19. Suggestions and recommendations are made for preventive and promotive public health strategies.\u0000\u0000\u0000\u0000The Salutogenesis model and Positive Psychology Interventions (PPI) provide another preventive and promotive public health management approach.\u0000","PeriodicalId":36711,"journal":{"name":"Current Psychiatry Research and Reviews","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2022-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42811978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-08-22DOI: 10.2174/2666082218666220822163152
M. Colizzi, Giulia Antolini, Elena Puttini, R. Bortoletto, Carolina Begnini, L. Zoccante
Factitious Disorder is a condition included among psychiatric disorders, where symptoms are intentionally produced to seek medical attention. Its epidemiology, treatment, and outcome are largely unknown. To increase knowledge of the condition, we discuss a pediatric case where the patient feigned neuropsychiatric symptoms. A 15-year-old female adolescent presented with neuropsychiatric symptoms suggestive of rare conditions such as Delusional Misidentification Syndrome [i.e., Capgras and Fregoli syndromes] and Developmental Prosopagnosia as well as epileptic seizures. When a Delusional Misidentification Syndrome was suspected, she was treated with Risperidone. Due to suboptimal response, Alprazolam and Sertraline were added and then Risperidone was cross-titrated to Haloperidol. The condition severity led to her admission to an inpatient Child and Adolescent Neuropsychiatry Unit. MRI scan and electroencephalographic recording were normal. The self- and parent-reported psychological assessment indicated several psychiatric symptoms. Instead, the clinician-administered Minnesota Multiphasic Personality Inventory-Adolescent and Structured Inventory of Malingered Symptomatology suggested a fake-bad profile and neuropsychiatric symptom simulation. Along with evidence of incongruent symptoms between the patient’s interviews, such investigations led to the diagnosis of Factitious Disorder. Psychopharmacological treatment was discontinued, and psychological support was offered to the patient and her parents. Increasing knowledge about Factitious Disorder is needed.
{"title":"Feigning Capgras Syndrome and Developmental Prosopagnosia: a rare case of Pediatric Factitious Disorder?","authors":"M. Colizzi, Giulia Antolini, Elena Puttini, R. Bortoletto, Carolina Begnini, L. Zoccante","doi":"10.2174/2666082218666220822163152","DOIUrl":"https://doi.org/10.2174/2666082218666220822163152","url":null,"abstract":"\u0000\u0000Factitious Disorder is a condition included among psychiatric disorders, where symptoms are intentionally produced to seek medical attention. Its epidemiology, treatment, and outcome are largely unknown.\u0000\u0000\u0000\u0000To increase knowledge of the condition, we discuss a pediatric case where the patient feigned neuropsychiatric symptoms.\u0000\u0000\u0000\u0000A 15-year-old female adolescent presented with neuropsychiatric symptoms suggestive of rare conditions such as Delusional Misidentification Syndrome [i.e., Capgras and Fregoli syndromes] and Developmental Prosopagnosia as well as epileptic seizures.\u0000\u0000\u0000\u0000When a Delusional Misidentification Syndrome was suspected, she was treated with Risperidone. Due to suboptimal response, Alprazolam and Sertraline were added and then Risperidone was cross-titrated to Haloperidol. The condition severity led to her admission to an inpatient Child and Adolescent Neuropsychiatry Unit. MRI scan and electroencephalographic recording were normal. The self- and parent-reported psychological assessment indicated several psychiatric symptoms. Instead, the clinician-administered Minnesota Multiphasic Personality Inventory-Adolescent and Structured Inventory of Malingered Symptomatology suggested a fake-bad profile and neuropsychiatric symptom simulation. Along with evidence of incongruent symptoms between the patient’s interviews, such investigations led to the diagnosis of Factitious Disorder. Psychopharmacological treatment was discontinued, and psychological support was offered to the patient and her parents.\u0000\u0000\u0000\u0000Increasing knowledge about Factitious Disorder is needed.\u0000","PeriodicalId":36711,"journal":{"name":"Current Psychiatry Research and Reviews","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2022-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44065765","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-08-22DOI: 10.2174/2666082218666220822161347
Jorge Eduardo Navarro- Obeid, Efraín Javier De la Hoz-Granadillo, María Laura Vergara Álvarez
The world health organization has indicated that the problem of COVID-19 and confinement generated strong psychological impacts on the world population. Much of the research has focused on studying mental health in different population groups, leaving aside a positive mental health perspective. The intention of the present research was to establish positive mental health profiles in confined women due to COVID-19 during 2020. The factors of personal satisfaction, prosocial attitude, self-control, autonomy, problema-solving, self-actualization, and interpersonal relationships were assessed through the application of Lluch's positive mental health scale, in a sample of 202 confined women in the Department of Sucre, Colombia, selected by non-probabilistic convenience sampling. In addition, cluster analysis models were applied to identify psychological profiles of positive mental health and characterize sociodemographic variables, the selected model was evaluated and validated using the statistical technique of discriminant analysis using Minitab 18 software showed a positive mental health differentiation in women from which four psychological profiles of positive mental health could be identified, with scores of 14.10 in profile 1, 11.41 in profile 2, 9.15 in profile 3, and 7.56 in profile 4. The positive mental health factors used showed an ability to discriminate in 92.6% of the cases in the profiles. the identified profiles are significant and important to characterize psychometric profiles of positive mental health of confined women, which are important results for their diagnosis and the development of public policies for their treatment.
{"title":"Psychological Profiles Of Positive Mental Health Of Women In Situation Of Confinement Due To Covid-19","authors":"Jorge Eduardo Navarro- Obeid, Efraín Javier De la Hoz-Granadillo, María Laura Vergara Álvarez","doi":"10.2174/2666082218666220822161347","DOIUrl":"https://doi.org/10.2174/2666082218666220822161347","url":null,"abstract":"\u0000\u0000The world health organization has indicated that the problem of COVID-19 and confinement generated strong psychological impacts on the world population. Much of the research has focused on studying mental health in different population groups, leaving aside a positive mental health perspective.\u0000\u0000\u0000\u0000The intention of the present research was to establish positive mental health profiles in confined women due to COVID-19 during 2020.\u0000\u0000\u0000\u0000The factors of personal satisfaction, prosocial attitude, self-control, autonomy, problema-solving, self-actualization, and interpersonal relationships were assessed through the application of Lluch's positive mental health scale, in a sample of 202 confined women in the Department of Sucre, Colombia, selected by non-probabilistic convenience sampling. In addition, cluster analysis models were applied to identify psychological profiles of positive mental health and characterize sociodemographic variables, the selected model was evaluated and validated using the statistical technique of discriminant analysis using Minitab 18 software\u0000\u0000\u0000\u0000showed a positive mental health differentiation in women from which four psychological profiles of positive mental health could be identified, with scores of 14.10 in profile 1, 11.41 in profile 2, 9.15 in profile 3, and 7.56 in profile 4. The positive mental health factors used showed an ability to discriminate in 92.6% of the cases in the profiles.\u0000\u0000\u0000\u0000the identified profiles are significant and important to characterize psychometric profiles of positive mental health of confined women, which are important results for their diagnosis and the development of public policies for their treatment.\u0000","PeriodicalId":36711,"journal":{"name":"Current Psychiatry Research and Reviews","volume":null,"pages":null},"PeriodicalIF":0.4,"publicationDate":"2022-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41265285","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：